Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul U Cameron

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Plos One|August 11, 2011
Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohortPaul U Cameron, Penelope Jones, Malgorzata Gorniak, et al.
Journal of Virology|April 13, 2018
The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and ReversedSimin D Rezaei, Hao K Lu, J Judy Chang, et al.
Retrovirology|June 7, 2011
Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitroVanessa A Evans, Luxshimi Lal, Ramesh Akkina, et al.
Nature Immunology|September 28, 2002
Diversity of receptors binding HIV on dendritic cell subsetsStuart G Turville, Paul U Cameron, Amanda Handley, et al.
Journal of Virological Methods|February 2, 2010
A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1Alyssa Cornall, Laveena Sharma, Ajantha Solomon, et al.
European Journal of Immunology|June 5, 2003
Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexesRichard M Coles, Claerwen M Jones, Andrew G Brooks, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 5, 2011
Early events of HIV-1 infection: can signaling be the next therapeutic target?Kate L Jones, Redmond P Smyth, Cândida F Pereira, et al.
The Journal of Infectious Diseases|June 7, 2003
Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicityAjantha Solomon, Paul U Cameron, Michael Bailey, et al.
Plos One|June 16, 2011
Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational DatabaseReena Rajasuriar, Maelenn Gouillou, Tim Spelman, et al.
Antiviral Therapy|May 29, 2008
Cytokine profiling in abacavir hypersensitivity patientsCoral-Ann M Almeida, Annalise M Martin, David Nolan, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Plos One|August 11, 2011
Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohortPaul U Cameron, Penelope Jones, Malgorzata Gorniak, et al.
Journal of Virology|April 13, 2018
The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and ReversedSimin D Rezaei, Hao K Lu, J Judy Chang, et al.
Retrovirology|June 7, 2011
Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitroVanessa A Evans, Luxshimi Lal, Ramesh Akkina, et al.
Nature Immunology|September 28, 2002
Diversity of receptors binding HIV on dendritic cell subsetsStuart G Turville, Paul U Cameron, Amanda Handley, et al.
Journal of Virological Methods|February 2, 2010
A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1Alyssa Cornall, Laveena Sharma, Ajantha Solomon, et al.
European Journal of Immunology|June 5, 2003
Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexesRichard M Coles, Claerwen M Jones, Andrew G Brooks, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 5, 2011
Early events of HIV-1 infection: can signaling be the next therapeutic target?Kate L Jones, Redmond P Smyth, Cândida F Pereira, et al.
The Journal of Infectious Diseases|June 7, 2003
Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicityAjantha Solomon, Paul U Cameron, Michael Bailey, et al.
Plos One|June 16, 2011
Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational DatabaseReena Rajasuriar, Maelenn Gouillou, Tim Spelman, et al.
Antiviral Therapy|May 29, 2008
Cytokine profiling in abacavir hypersensitivity patientsCoral-Ann M Almeida, Annalise M Martin, David Nolan, et al.
Pageof 10